Third Class Of Drugs Should Not Be “Completely Closed Down” – Ganley
This article was originally published in The Tan Sheet
Executive Summary
Debate on the merits of a third class of drugs could resurface as FDA considers Rx-to-OTC switch applications of drugs indicated for chronic conditions